These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The Use of Peripheral μ-Opioid Receptor Antagonists (PAMORA) in the Management of Opioid-Induced Constipation: An Update on Their Efficacy and Safety. Pergolizzi JV; Christo PJ; LeQuang JA; Magnusson P Drug Des Devel Ther; 2020; 14():1009-1025. PubMed ID: 32210534 [TBL] [Abstract][Full Text] [Related]
23. Management of Opioid-Induced Constipation and Bowel Dysfunction: Expert Opinion of an Italian Multidisciplinary Panel. De Giorgio R; Zucco FM; Chiarioni G; Mercadante S; Corazziari ES; Caraceni A; Odetti P; Giusti R; Marinangeli F; Pinto C Adv Ther; 2021 Jul; 38(7):3589-3621. PubMed ID: 34086265 [TBL] [Abstract][Full Text] [Related]
24. Naldemedine versus placebo in opioid-induced constipation: a meta-analysis. Wobbe B; Gerner M; Köhne CH BMJ Support Palliat Care; 2024 Jan; 13(e3):e578-e584. PubMed ID: 36517204 [TBL] [Abstract][Full Text] [Related]
25. Peripherally acting opioid antagonists in the treatment of opiate-related constipation: a systematic review. Becker G; Galandi D; Blum HE J Pain Symptom Manage; 2007 Nov; 34(5):547-65. PubMed ID: 17900855 [TBL] [Abstract][Full Text] [Related]
27. The role of oxycodone/naloxone in the management of patients with pain and opioid-induced constipation. Leppert W; Zajaczkowska R; Wordliczek J Expert Opin Pharmacother; 2019 Apr; 20(5):511-522. PubMed ID: 30625013 [TBL] [Abstract][Full Text] [Related]
28. Use of Peripheral μ-Opioid Receptor Antagonists for Treating Opioid-Induced Constipation among US Medicare Beneficiaries from 2014 to 2018. Premnath N; Sumarsono A; Sedhom R; Johnson DH; Subbiah IM; Dy SM; Gupta A J Palliat Med; 2021 Aug; 24(8):1236-1239. PubMed ID: 33872062 [No Abstract] [Full Text] [Related]
29. Randomized, Double-Blind Trial of Oral Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Chronic Noncancer Pain. Rauck R; Slatkin NE; Stambler N; Harper JR; Israel RJ Pain Pract; 2017 Jul; 17(6):820-828. PubMed ID: 27860208 [TBL] [Abstract][Full Text] [Related]
30. Randomised clinical trial: the long-term safety and tolerability of naloxegol in patients with pain and opioid-induced constipation. Webster L; Chey WD; Tack J; Lappalainen J; Diva U; Sostek M Aliment Pharmacol Ther; 2014 Oct; 40(7):771-9. PubMed ID: 25112584 [TBL] [Abstract][Full Text] [Related]
31. Insights into the Use of Peripherally Acting μ-Opioid Receptor Antagonists (PAMORAs) in Oncologic Patients: from Scientific Evidence to Real Clinical Practice. Fernández-Montes A; de Velasco G; Aguín S; Farriols C; Guirado-Risueño M; Jerviz-Guía VG; Baeza-Nadal MV; Chicas-Sett R; Fírvida JL; García-Navalón F; Martín P; Perezagua-Marín C; Rodríguez D; Santamaría J; Saurí T; Cobo M Curr Treat Options Oncol; 2021 Feb; 22(3):26. PubMed ID: 33635493 [TBL] [Abstract][Full Text] [Related]
33. Cost Effectiveness of Naloxegol for Opioid-Induced Constipation in the UK. Lawson R; Ryan J; King F; Goh JW; Tichy E; Marsh K Pharmacoeconomics; 2017 Feb; 35(2):225-235. PubMed ID: 27663572 [TBL] [Abstract][Full Text] [Related]
34. Opioid-induced Constipation: A Review of Health-related Quality of Life, Patient Burden, Practical Clinical Considerations, and the Impact of Peripherally Acting μ-Opioid Receptor Antagonists. Argoff CE Clin J Pain; 2020 Sep; 36(9):716-722. PubMed ID: 32554978 [TBL] [Abstract][Full Text] [Related]
35. Emerging therapies for opioid-induced constipation: what can we expect? Roostaei G; Khoshnam Rad N; Fakhri B MS; Nikfar S; Abdollahi M Expert Opin Pharmacother; 2024 Sep; 25(13):1729-1738. PubMed ID: 39308446 [TBL] [Abstract][Full Text] [Related]
36. Treating opioid-induced constipation in patients taking other medications: Avoiding CYP450 drug interactions. Raffa RB; Taylor R; Pergolizzi JV J Clin Pharm Ther; 2019 Jun; 44(3):361-371. PubMed ID: 30793348 [TBL] [Abstract][Full Text] [Related]
38. Opioid-induced constipation. Wein S J Pain Palliat Care Pharmacother; 2012 Dec; 26(4):382-4. PubMed ID: 23216186 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of a Pharmacist-Driven Protocol for the Treatment of Opioid-Induced Constipation. Tryson AR; Hennessey EK; Crannage AJ J Pharm Pract; 2022 Apr; 35(2):218-222. PubMed ID: 35484871 [TBL] [Abstract][Full Text] [Related]
40. [Opioid-Induced Constipation in Patients with Cancer Pain]. Aruga E Gan To Kagaku Ryoho; 2021 Nov; 48(11):1311-1315. PubMed ID: 34795117 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]